{ "id": 453, "date": "2026-04-30T09:13:49", "date_gmt": "2026-04-30T09:13:49", "guid": { "rendered": "https:\/\/pixels.ch\/?post_type=industry&p=453" }, "modified": "2026-06-17T21:29:37", "modified_gmt": "2026-06-17T21:29:37", "slug": "pharma-healthcare", "status": "publish", "type": "industry", "link": "https:\/\/pixels.ch\/en\/industry\/pharma-healthcare\/", "title": { "rendered": "Pharma & Healthcare" }, "content": { "rendered": "
\n
\n

Your Challenges<\/h2>\n\n\n\n

Four problems
we see every time.<\/h3>\n<\/div>\n\n\n\n
\n\n
\n
\n 1. \n <\/div>\n\n

\n Regulatory complexity <\/h3>\n
\n

HCP vs. patient communication, Swissmedic requirements, off-label restrictions. Every piece of content needs compliance review.<\/p>\n <\/div>\n <\/div>\n\n<\/div>\n\n\n\n

\n\n
\n
\n 2. \n <\/div>\n\n

\n Multiple audiences <\/h3>\n
\n

Healthcare professionals, patients, caregivers, pharmacists. Each requires different messaging, different evidence, different channels.<\/p>\n <\/div>\n <\/div>\n\n<\/div>\n\n\n\n

\n\n
\n
\n 3. \n <\/div>\n\n

\n Content at scale <\/h3>\n
\n

Product launches, congresses, disease awareness campaigns. The content machine never stops, and everything must be reviewed.<\/p>\n <\/div>\n <\/div>\n\n<\/div>\n\n\n\n

\n\n
\n
\n 4. \n <\/div>\n\n

\n Digital Scepticism <\/h3>\n
\n

Many pharma companies are still cautious about digital. Proving ROI in a regulated environment is harder but not impossible.<\/p>\n <\/div>\n <\/div>\n\n<\/div>\n\n<\/div>\n<\/section>\n\n\n\n

\n
\n
\n
\n

How we help<\/h2>\n\n\n\n

We did not learn the rules from a manual.<\/mark> We learned them in real campaigns.<\/h3>\n<\/div>\n<\/div>\n\n\n\n
\n
\n

For Galderma, we developed a content matrix that structures what can be said, to whom, through which channel. A system that makes compliance easier, not harder.<\/p>\n\n\n\n

For Mebuca\u00efne (also Galderma), we designed a product finder that guides patients to the right product through an intuitive interface. UX strategy to wireframe.<\/p>\n\n\n\n

For Spirig, we built a content strategy that works within the regulatory framework while still being engaging and effective.<\/p>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n\n
\n
\n 100% \n <\/div>\n\n

\n Compliant thinking <\/h3>\n
\n

Content systems, governance and workflows designed around regulatory requirements from the start.<\/p>\n <\/div>\n <\/div>\n\n<\/div>\n\n\n\n

\n\n
\n
\n 5+ \n <\/div>\n\n

\n Healthcare brands <\/h3>\n
\n

Supporting pharmaceutical and healthcare companies with content, UX and communication strategies.<\/p>\n <\/div>\n <\/div>\n\n<\/div>\n\n\n\n

\n\n
\n
\n Content \n <\/div>\n\n

\n Strategic <\/h3>\n
\n

Engaging communication that works within regulatory frameworks without losing effectiveness.<\/p>\n <\/div>\n <\/div>\n\n<\/div>\n\n<\/div>\n<\/section>", "protected": false }, "excerpt": { "rendered": "

Pharma communication in Switzerland means: know the rules, find the room. What you can say, to whom, through which channel. It’s all regulated. But within those boundaries, there’s more creative space than most companies use.<\/p>", "protected": false }, "featured_media": 2484, "template": "", "meta": { "_acf_changed": true }, "class_list": [ "post-453", "industry", "type-industry", "status-publish", "has-post-thumbnail", "hentry" ], "acf": [], "_links": { "self": [ { "href": "https:\/\/pixels.ch\/en\/wp-json\/wp\/v2\/industry\/453", "targetHints": { "allow": [ "GET" ] } } ], "collection": [ { "href": "https:\/\/pixels.ch\/en\/wp-json\/wp\/v2\/industry" } ], "about": [ { "href": "https:\/\/pixels.ch\/en\/wp-json\/wp\/v2\/types\/industry" } ], "wp:featuredmedia": [ { "embeddable": true, "href": "https:\/\/pixels.ch\/en\/wp-json\/wp\/v2\/media\/2484" } ], "wp:attachment": [ { "href": "https:\/\/pixels.ch\/en\/wp-json\/wp\/v2\/media?parent=453" } ], "curies": [ { "name": "wp", "href": "https:\/\/api.w.org\/{rel}", "templated": true } ] } }